U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 18,050
-1,440 (-7.39%)
At close: Apr 29, 2026
456.24% (1Y)
| Market Cap | 290.77B +703.8% |
| Revenue (ttm) | 25.59B +2.2% |
| Net Income | -1.64B |
| EPS | -141.00 |
| Shares Out | 15.93M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (0.49%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 353,074 |
| Average Volume | 547,851 |
| Open | 19,450 |
| Previous Close | 19,490 |
| Day's Range | 17,910 - 20,200 |
| 52-Week Range | 2,900 - 32,800 |
| Beta | 1.89 |
| RSI | 49.16 |
| Earnings Date | n/a |